Skip to content

Assessment of High Flow Nasal Cannula Oxygenation in EBUS Bronchoscopy

Assessment of High Flow Nasal Cannula Oxygenation in EBUS Bronchoscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03226964
Acronym
AHOE
Enrollment
40
Registered
2017-07-24
Start date
2016-10-01
Completion date
2018-04-01
Last updated
2018-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Lymphadenopathy

Keywords

endobronchial ultrasound, high flow nasal oxygen

Brief summary

This study is a prospective randomised trial where a computer will randomly allocate patients to one of two possible methods of delivering oxygen during the procedure of bronchoscopy. This trial compares high flow nasal cannula (HFNC) with nasal prongs in delivering oxygen to patients undergoing endo-bronchial ultrasound guided trans- bronchial nodal aspiration (EBUS-TBNA) a specialised form of bronchoscopy procedure. HFNC uses humidified higher gas flow rates than conventional low flow systems such as nasal prongs which are limited by the respiratory rate and effort.

Interventions

humidified high flow nasal oxygen

Sponsors

University College Hospital Galway
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects with a peripheral arterial pulse oximetry ≥ 90% breathing room air * Age ≥ 18 years * Able to breathe spontaneously throughout the procedure

Exclusion criteria

* Respiratory or cardiac failure * Recent myocardial infarction \< 6 weeks ago * On long term oxygen therapy, those with tracheostomy and/ or non-invasive or invasive mechanical ventilation * Nasal and/ or nasopharyngeal disease * Inability to give informed consent * Dementia * Hepatic or end stage renal disease * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
drop in oxygen saturation during procedurethrough procedure completion defined as withdrawing scope from patient's mouth, an average of 30 minutesthe difference in oxygen saturation levels between pre-treatment assessments and the lowest saturation level achieved during treatment

Secondary

MeasureTime frameDescription
change in venous CO21 hour after procedureChange in venous CO2 1 hour after procedure compared to pre-procedure level
end tidal CO2 during procedurethrough procedure completion defined as withdrawing scope from patient's mouth an average of 30 minutesMeasured with tip of scope at lower trachea
Patient experience measure on a visual analogue scaleup to 3 hours after procedure
endotracheal intubation during or post procedure24 hours

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026